Severance Agreements in the Pharmaceuticals Industry

186 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
ZOETIS EXECUTIVE SEVERANCE PLAN
Severance Agreements
Zoetis
Pharmaceuticals
NJ
2013
General Release and Severance Agreement, by and between MyMD Pharmaceuticals, Inc. and Christopher Chapman, dated as of June 14, 2024
Severance Agreements
Akers Biosciences, Inc.
2024
Organon & Co. Executive Severance Program, as amended and restated on February 8, 2024
Severance Agreements
Organon & Co.
2024
Amended and Restated Executive Severance Benefit Plan
Severance Agreements
Revance Therapeutics, Inc.
2024
Form of Severance Agreement between non-US-based executive officers and Catalent Pharma Solutions, Inc
Severance Agreements
Catalent Inc
2023
Form of Severance Agreement between US-based executive officers and Catalent Pharma Solutions, Inc
Severance Agreements
Catalent Inc
2023
Rain Oncology Inc. Amended and Restated Executive Severance Plan
Severance Agreements
Rain Therapeutics Inc.
2023
Pfizer Inc. Executive Officer Severance Policy
Severance Agreements
Pfizer
2023
Severance Agreement by and between the Company and Fabio Cataldi, effective as of September 5, 2022
Severance Agreements
Landos Biopharma, Inc.
2023
Severance Agreement and Release, dated October 28, 2022, by and between Nancy Huber and Medicine Man Technologies, Inc
Severance Agreements
Medicine Man Technologies, Inc.
Pharmaceuticals
CO
2023
Amendment No. 4 to the Pfizer Inc. Executive Severance Plan
Severance Agreements
Pfizer
Pharmaceuticals
2023
Severance and Settlement Agreement and Release of All Claims, dated February 9, 2023, by and between the Company and Michael Valentino
Severance Agreements
PLx Pharma Inc.
Pharmaceuticals
2023
Severance Agreement and General Release, dated as of June 28, 2022, by and between Liquidia Technologies, Inc. and Tushar Shah, M.D
Severance Agreements
Liquidia Corp
Pharmaceuticals
NC
2022
AN2 Therapeutics, Inc. Officer Severance Plan
Severance Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022
Severance and General Release Agreement, dated March 1, 2022, between Andrew Gesek and Petros Pharmaceuticals, Inc., its affiliates, subsidiaries and successor entities
Severance Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2022
Cara Therapeutics, Inc. Severance Plan and Form of Participation Agreement
Severance Agreements
Cara Therapeutics, Inc.
Pharmaceuticals
CT
2022
Severance Agreement and General Release, dated as of January 7, 2022, by and between the Registrant and David Gordon
Severance Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Severance Agreement and General Release, dated as of November 1, 2021, by and between the Registrant and Kamil Ali-Jackson
Severance Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Severance Protection Letter, dated February 7, 2022, by and between Damian Finio and Phibro Animal Health Corporation
Severance Agreements
Phibro Animal Health Corporation
Pharmaceuticals
DE
2022
Mallinckrodt Pharmaceuticals Severance Plans for U.S. Officers and Executives, Amended September 8, 2021
Severance Agreements
Mallinckrodt
Pharmaceuticals
2021
Rain Therapeutics Inc. Executive Severance Plan and Form of Participation Agreement
Severance Agreements
Rain Therapeutics Inc.
Pharmaceuticals
CA
2021
Severance Agreement and Release between Leonardo Riera and Medicine Man Technologies, Inc
Severance Agreements
Medicine Man Technologies, Inc.
Pharmaceuticals
CO
2021
Severance, General Waiver and Release Agreement with Nicolle Dorsey dated February 3, 2021
Severance Agreements
4Front Ventures Corp.
Pharmaceuticals
AZ
2021
Severance, General Waiver and Release Agreement with Jerry Derevanny dated June 30, 2020
Severance Agreements
4Front Ventures Corp.
Pharmaceuticals
AZ
2021
Severance, General Waiver and Release Agreement with Brad Kotansky dated March 27, 2020
Severance Agreements
4Front Ventures Corp.
Pharmaceuticals
AZ
2021
Severance Agreement entered into on December 3, 2020 by and between Viatris Inc. and Michael Goettler
Severance Agreements
Upjohn Inc
Pharmaceuticals
2021
Elanco Executive Severance Pay Plan and Summary
Severance Agreements
Elanco Animal Health Inc
Pharmaceuticals
IN
2021
Amendment No. 3 to the Pfizer Inc. Executive Severance Plan
Severance Agreements
Pfizer
Pharmaceuticals
2021
Senior Executive Severance Plan, effective as of April 26, 2007 and as amended and restated effective as of January 1, 2021
Severance Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Severance Agreement and General Release, dated as of January 13, 2021, by and between Liquidia Technologies, Inc. and Neal F. Fowler
Severance Agreements
Liquidia Corp
Pharmaceuticals
2021
Amneal Pharmaceuticals LLC Severance Plan and Summary Plan Description
Severance Agreements
Amneal Pharmaceuticals, Inc.
Pharmaceuticals
2020
Mallinckrodt Pharmaceuticals Severance Plan for U.S. Officers and Executives
Severance Agreements
Mallinckrodt
Pharmaceuticals
2020
Executive Severance Plan
Severance Agreements
PLIANT THERAPEUTICS, INC.
Pharmaceuticals
DE
2020
Perrigo Company Employee Severance Programme - Ireland, effective April 9, 2020
Severance Agreements
Perrigo
Pharmaceuticals
2020
Severance Agreement and Release, dated February 25, 2020
Severance Agreements
Medicine Man Technologies, Inc.
Pharmaceuticals
CO
2020
Tricida, Inc. Executive Severance Plan
Severance Agreements
Tricida, Inc.
Pharmaceuticals
CA
2020
Amendment No. 2 to the Pfizer Inc. Executive Severance Plan
Severance Agreements
Pfizer
Pharmaceuticals
2020
Perrigo Company Employee Severance Programme - Ireland, effective December 19, 2019
Severance Agreements
Perrigo
Pharmaceuticals
2020
Severance Agreement and General Release, effective as of November 30, 2019, by and between Liquidia Technologies, Inc. and Timothy Albury
Severance Agreements
Liquidia Technologies Inc
Pharmaceuticals
2019
Mylan N.V. Severance Plan and Global Guidelines
Severance Agreements
Mylan N.V.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Executive Severance Benefit Plan, Amended and Restated effective October 13, 2019
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019